RxDoctor Payments Data

Marjorie Oropilla, MD

Interventional Pain Medicine · Newburgh, INNPI 1477717296

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 64.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2022 at $941 and has fallen 88.8% since, to $106 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.

$3,929in general payments, 2019–2025

Across 205 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Radius Health, Inc.$152
  • Medtronic$150
  • Amgen$132
  • Novartis$122
  • Stimwave Technologies Incorporated$109
  • plus $720 from 19 others

What the payments were for

  • Food & beverage$3,929100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,929 in reported general payments places this provider in the 45th percentile of 68 interventional pain medicine providers in Indiana.

See all interventional pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$104,519
Medicare patients
392
Services billed
1,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen249$5,836
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$2,133
Pregabalin61$1,969
Gabapentin127$1,794
Baclofen29$822
Tizanidine Hcl60$774
Morphine Sulfate ErMorphine Sulfate20$748
Diclofenac Sodium33$613
Oxycodone Hcl33$554
Tramadol Hcl84$508
Duloxetine Hcl30$501
Meloxicam38$486
Amitriptyline Hcl31$262
Methylprednisolone23$126
Cyclobenzaprine Hcl26$93

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →